Studies have shown that loss of IL‐24 expression is correlated with disease progression in prostate cancer 5, breast cancer 6, colon cancer 7, neuroblastoma 8, acute leukemia 9, oral squamous cell carcinoma 10, 11, lung cancer 12 and other cancers 13, 14, 15, 16, 17. Here, IL24 is linked to cancer.